EFFECTOR THERAPEUTICS
Why Robinhood?
You can watch EFTR and buy or sell other stocks, ETFs, and their options commission-free!About EFTR
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2).
EFTR Key Statistics
Stock Snapshot
The current EFFECTOR THERAPEUTICS(EFTR) stock price is $0.00, with a market capitalization of 51.7K. The stock trades at a price-to-earnings (P/E) ratio of -12.57.
EFFECTOR THERAPEUTICS(EFTR) stock opened on 2026-10-27 at —. The price climbed to — and dipped to —.
The EFFECTOR THERAPEUTICS(EFTR)'s current trading volume is 0, compared to an average daily volume of 2.96M.
During the past year, EFFECTOR THERAPEUTICS(EFTR) stock moved between $0.34 at its lowest and $1.48 at its peak.
During the past year, EFFECTOR THERAPEUTICS(EFTR) stock moved between $0.34 at its lowest and $1.48 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.